A comprehensive analysis of APOE genotype effects on human brain structure in the UK Biobank.
Heise V. et al, (2024), Transl Psychiatry, 14
The lifetime accumulation of multimorbidity and its influence on dementia risk: a UK Biobank Study
Patel R. et al, (2024), medRxiv
Investigating the brain's neurochemical profile at midlife in relation to dementia risk factors.
Dounavi M-E. et al, (2024), Brain Commun, 6
Trichotillomania: a perspective synthesised from neuroscience and lived experience.
Mackay CE., (2023), BMJ Ment Health, 26
Oxford brain health clinic: protocol and research database.
O'Donoghue MC. et al, (2023), BMJ Open, 13
Modifiable and non-modifiable risk factors of dementia on midlife cerebral small vessel disease in cognitively healthy middle-aged adults: the PREVENT-Dementia study.
Low A. et al, (2022), Alzheimers Res Ther, 14
Adapting UK Biobank imaging for use in a routine memory clinic setting: the Oxford Brain Health Clinic
Griffanti L. et al, (2022)
Inter- and intra-individual variation in brain structural-cognition relationships in aging.
Patel R. et al, (2022), Neuroimage, 257
Macrostructural brain alterations at midlife are connected to cardiovascular and not inherited risk of future dementia: the PREVENT-Dementia study.
Dounavi M-E. et al, (2022), J Neurol, 269, 4299 - 4309
Associations of cognitive performance with cardiovascular magnetic resonance phenotypes in the UK Biobank.
Raisi-Estabragh Z. et al, (2022), Eur Heart J Cardiovasc Imaging, 23, 663 - 672
Association of cerebral small vessel disease burden with brain structure and cognitive and vascular risk trajectories in mid-to-late life.
Jansen MG. et al, (2022), J Cereb Blood Flow Metab, 42, 600 - 612
Mapping brain structural differences and neuroreceptor correlates in Parkinson's disease visual hallucinations.
Vignando M. et al, (2022), Nat Commun, 13
International Multicenter Analysis of Brain Structure Across Clinical Stages of Parkinson's Disease.
Laansma MA. et al, (2021), Mov Disord, 36, 2583 - 2594